Alzheimer’s disease biomarkers galvanise rocky drug development space
At CTAD 2022, several studies on biomarkers offered the opportunity to improve the scope of clinical research for dementia.
Features
Humira biosimilars set the stage for long-awaited 2023 US launches
CMO Moves: Regulatory Catalysts for Drug Manufacturing-November
The “Medical Bypass”: New drugs to strike obesity
Ketamine: Could this anesthetic be the key to treating neurological disorders?
Magazine: What Rishi Sunak can do for the UK pharma industry
What do companies need from COP27?
Artificial intelligence hiring levels in the pharma industry dropped in October 2022
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
